ATOS Quote, Trading Chart, Atossa Genetics Inc.
home / stock / atos / atos quote
$5.14 Last:
10.54% Change Percent:
$4.66 Open:
$5.14 Previous Close:
$5.55 High:
$4.62 Low:
22,808,338 Volume:
06/17/2021 04:42:32 am Last Trade Date Time:
Quotes are delayed by 15 to 20 minutes.
ATOS Last Five Trading Days
| Stock Date | Open Price | Close Price | High | Low | Volume |
|---|---|---|---|---|---|
| 2021-06-17 | 4.66 | 5.14 | 5.55 | 4.62 | 22,808,338 |
| 2021-06-16 | 4.64 | 4.65 | 4.72 | 4.45 | 7,557,764 |
| 2021-06-15 | 4.63 | 4.62 | 4.8 | 4.435 | 8,042,777 |
| 2021-06-14 | 4.41 | 4.62 | 4.84 | 4.35 | 13,876,411 |
| 2021-06-11 | 4.48 | 4.31 | 4.49 | 4.12 | 13,621,481 |
| 2021-06-10 | 4.15 | 4.07 | 4.68 | 3.83 | 25,182,921 |
| 2021-06-09 | 5.57 | 4.4 | 5.8 | 4.15 | 54,173,992 |
| 2021-06-08 | 6.3 | 6.07 | 6.82 | 4.82 | 43,200,489 |
| 2021-06-07 | 4.9 | 6.01 | 6.39 | 4.9 | 62,228,597 |
| 2021-06-04 | 4.5453 | 4.62 | 4.92 | 4.22 | 17,201,696 |
| 2021-06-03 | 3.94 | 4.44 | 4.67 | 3.87 | 19,485,500 |
| 2021-06-02 | 3.99 | 3.94 | 4.24 | 3.54 | 22,759,745 |
| 2021-06-01 | 3.32 | 3.87 | 3.99 | 3.31 | 20,499,278 |
| 2021-05-31 | 3.18 | 3.22 | 3.295 | 3.16 | 4,988,754 |
| 2021-05-28 | 3.18 | 3.22 | 3.295 | 3.16 | 4,915,500 |
| 2021-05-27 | 3.14 | 3.18 | 3.26 | 3.07 | 6,076,167 |
| 2021-05-26 | 3 | 3.12 | 3.2 | 2.91 | 6,923,789 |
| 2021-05-25 | 3.17 | 3.06 | 3.245 | 3.04 | 6,051,360 |
| 2021-05-24 | 3.24 | 3.16 | 3.29 | 3.13 | 6,176,427 |
| 2021-05-21 | 3.26 | 3.23 | 3.395 | 3.2 | 11,243,867 |
News, Short Squeeze, Breakout and More Instantly...
-
SEATTLE, June 16, 2021 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq:ATOS), a clinical stage biopharmaceutical company seeking to discover and develop innovative medicines in areas of significant unmet medical need with a current focus on breast cancer and COVID-19, today announced ...
-
4 Biotech Penny Stocks For Your June Watchlist Are you considering buying penny stocks this June? Trading penny stocks has been extremely popular this year. With low prices and high volatility, the potential for rapid portfolio growth is an exciting prospect for investors to conside...
-
SEATTLE, June 11, 2021 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company seeking to discover and develop innovative medicines in oncology and infectious disease with a current focus on breast cancer and COVID-19, announces that it has r...